Common Contracts

SETTLEMENT AGREEMENT

Settlement Agreement • September 27th, 2012 • Lorus Therapeutics Inc • Biological products, (no disgnostic substances) • Ontario

• Contract Type
  Settlement Agreement
• Filed
  September 27th, 2012
• Company
  Lorus Therapeutics Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Ontario

WHEREAS on October 6, 2004, Lorus Therapeutics Inc. (formerly 4325231 Canada Inc.) (“Old Lorus”), GeneSense Technologies Inc. (“GeneSense”) and TEMIC entered into a subscription agreement (as amended, restated, supplemented or otherwise modified from time to time, the “Subscription Agreement”) providing for the issuance of three (3) five million dollar ($5,000,000) principal amount convertible debentures (each a “Debenture” and collectively, the “Debentures”) on each of October 6, 2004, January 14, 2005 and April 15, 2005, each maturing on October 6, 2009;

SETTLEMENT AGREEMENT

Settlement Agreement • November 16th, 2009 • Lorus Therapeutics Inc • Biological products, (no disgnostic substances) • Ontario

• Contract Type
  Settlement Agreement
• Filed
  November 16th, 2009
• Company
  Lorus Therapeutics Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Ontario

WHEREAS on October 6, 2004, Lorus Therapeutics Inc. (formerly 4325231 Canada Inc.) (“Old Lorus”), GeneSense Technologies Inc. (“GeneSense”) and TEMIC entered into a subscription agreement (as amended, restated, supplemented or otherwise modified from time to time, the “Subscription Agreement”) providing for the issuance of three (3) five million dollar ($5,000,000) principal amount convertible debentures (each a “Debenture” and collectively, the “Debentures”) on each of October 6, 2004, January 14, 2005 and April 15, 2005, each maturing on October 6, 2009;